Skip to Content


In the US, Gadobutrol (gadobutrol systemic) is a member of the drug class magnetic resonance imaging contrast media and is used to treat CNS Magnetic Resonance Imaging, Diagnosis and Investigation and Vascular Magnetic Resonance Imaging.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Contrast medium for NMR-tomography

Chemical Name

[10-[(1RS,2SR)-2,3-dihydroxy-1-(hydroxymetyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)]gadolinium (WHO)

Foreign Names

  • Gadobutrolum (Latin)
  • Gadobutrol (German)
  • Gadobutrol (French)
  • Gadobutrol (Spanish)

Generic Names

  • Gadobutrol (OS: DCF, USAN, JAN)
  • ZK 135079 (IS)

Brand Names

  • Gadavist
    Bayer HealthCare, United States
  • Gadograf 604.72mg
    Berlis, Switzerland
  • Gadovist
    Adeofarma, Lithuania; Bayer, Bosnia & Herzegowina; Bayer, Belgium; Bayer, Brazil; Bayer, Canada; Bayer, China; Bayer, Colombia; Bayer, Costa Rica; Bayer, Denmark; Bayer, Dominican Republic; Bayer, Estonia; Bayer, United Kingdom; Bayer, Georgia; Bayer, Greece; Bayer, Guatemala; Bayer, Honduras; Bayer, Croatia (Hrvatska); Bayer, Ireland; Bayer, Italy; Bayer, Latvia; Bayer, Malta; Bayer, Nicaragua; Bayer, Netherlands; Bayer, Norway; Bayer, New Zealand; Bayer, Pakistan; Bayer, Poland; Bayer, Sweden; Bayer, Slovenia; Bayer, Slovakia; Bayer, El Salvador; Bayer, Turkey; Bayer Australia, Australia; Bayer HealthCare, Finland; Bayer Hellas Abee, Cyprus; Bayer Hispania, Spain; Bayer Pharma, Romania; Bayer Pharma, Serbia; Bayer Santé, France; Bayer Schering, Bulgaria; Bayer Schering, Lithuania; Bayer Schering Pharma, Russian Federation; Bayer Vital, Germany; Bayer Yakuhin, Japan; Lex ano, Lithuania; Lusal, Portugal; Bayer Schweiz, Switzerland
  • Gadovist 1
    Bayer, Luxembourg
  • Gadovist 1,0 mmol/ml
    Bayer Austria, Austria
  • Gadovist 1.0
    Bayer AB, Iceland
  • Gadovist 1.0 mmol/ml
    Bayer, Hungary
  • Gadovist PFS-1
    Bayer, Luxembourg


DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.